Dietary Supplements

Browse Dietary Supplements Content

As many dietary supplement products are being marketed as containing cannabidiol (CBD), CHPA has an interest in this subject and we presented oral comments at FDA’s May 31, 2019, public hearing. These written comments supplement our oral remarks.

Jul 16, 2019

Herein, the Consumer Healthcare Products Association provides feedback on the Food and Drug Administration (FDA) request for comments on Responsible Innovation on Dietary Supplements.

Jul 15, 2019

CHPA supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. Hemp oil is already an appropriate dietary ingredient.

Mar 18, 2019

CHPA has reviewed the findings of the meeting of the World Health Organization Expert Committee on Drug Dependence. CHPA agrees with the Committee's recommendations.

Mar 14, 2019

Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics).

Nov 6, 2018

Herein, CHPA provides feedback on the Food and Drug Administration’s Nutrition Innovation Strategy, particularly as it relates to the agency’s development and implementation of a consumer education campaign.

Oct 11, 2018

The dietary supplement industry’s self-regulatory coalition, the SIDI Work Group, today released an updated version of the Standardized Information on Dietary Ingredients (SIDI TM) Protocol.

Sep 10, 2018

Herein, CHPA provides feedback on the Agricultural Marketing Service (AMS) request for comments on a Proposed Rule to establish the national mandatory bioengineered food disclosure standard.

Jul 3, 2018

State by state listing of whether OTC medicines are exempt from state sales tax or not.

Jun 1, 2018

Best practices for consumers looking to make evidence-informed decisions when shopping for dietary supplements, including avoiding red-flag ingredients such as SARMs.

Mar 7, 2018

Filter Results